InsidersTradesSigma
Follow the 대한뉴팜 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 대한뉴팜 has recorded 46 insider filings. Market capitalisation: €78bn. The latest transaction was reported on 29 May 2026 (Purchase). Among the most active insiders: 이완진. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 46 declarations
대한뉴팜 es una empresa del sector sanitario y farmacéutico, que cotiza en la bolsa XKRX. Se especializa en el desarrollo y comercialización de productos farmacéuticos.